CNF1 exploits the ubiquitin-proteasome machinery to restrict Rho GTPase activation for bacterial host cell invasion

Cell

Volumn 111, Issue 4, 2002, Pages 553-564

  Doye, Anne ^a   Mettouchi, Amel ^b   Bossis, Guillaume ^c   Clément, René ^a   Buisson Touati, Caroline ^a   Flatau, Gilles ^a   Gagnoux, Laurent ^a   Piechaczyk, Marc ^c   Boquet, Patrice ^a   Lemichez, Emmanuel ^a  

^a INSERM   (France)

^b CENTRE ANTOINE LACASSAGNE   (France)

^c CNRS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GUANOSINE TRIPHOSPHATASE; PROTEASOME; RAC PROTEIN; UBIQUITIN; UNCLASSIFIED DRUG; VIRULENCE FACTOR; VIRULENCE FACTOR CNF1;

AMINO ACID SEQUENCE; ANIMAL TISSUE; ARTICLE; CELL INVASION; CELL MOTILITY; CONTROLLED STUDY; CYTOSOL; DEAMINATION; ENZYME ACTIVATION; ESCHERICHIA COLI; HOST CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT;

ANIMALIA; BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; NEGIBACTERIA;

EID: 18744379729     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0092-8674(02)01132-7     Document Type: Article

References (35)

1. Blanco J., Blanco M., Alonso M.P., Blanco J.E., Gonzalez E.A., Garabal J.I. Characteristics of haemolytic Escherichia coli with particular reference to production of cytotoxic necrotizing factor type 1 (CNF1). Res. Microbiol. 143:1992;869-878.
2. Blum G., Falbo V., Caprioli A., Hacker J. Gene clusters encoding the cytotoxic necrotizing factor type 1, Prs-fimbriae and alpha-hemolysin form the pathogenicity island II of the uropathogenic Escherichia coli strain J96. FEMS Microbiol. Lett. 126:1995;189-195.
3. Bonacorsi S.P., Clermont O., Tinsley C., Le Gall I., Beaudoin J.C., Elion J., Nassif X., Bingen E. Identification of regions of the Escherichia coli chromosome specific for neonatal meningitis-associated strains. Infect. Immun. 68:2000;2096-2101.
4. Boquet P. The cytotoxic necrotizing factor 1 (CNF1) from Escherichia coli. Toxicon. 39:2001;1673-1680.
5. Boquet P., Munro P., Fiorentini C., Just I. Toxins from anaerobic bacteria. specificity and molecular mechanisms of action Curr. Opin. Microbiol. 1:1998;66-74.
6. Buetow L., Flatau G., Chiu K., Boquet P., Ghosh P. Structure of the Rho-activating domain of Escherichia coli cytotoxic necrotizing factor 1. Nat. Struct. Biol. 8:2001;584-588.
7. Chardin P., Boquet P., Madaule P., Popoff M.R., Rubin E.J., Gill D.M. The mammalian G protein rhoC is ADP-ribosylated by Clostridium botulinum exoenzyme C3 and affects actin microfilaments in Vero cells. EMBO J. 8:1989;1087-1092.
8. Chau V., Tobias J.W., Bachmair A., Marriott D., Ecker D.J., Gonda D.K., Varshavsky A. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein. Science. 243:1989;1576-1583.
9. Falkow S., Small P., Isberg R., Hayes S.F., Corwin D. A molecular strategy for the study of bacterial invasion. Rev. Infect. Dis. 9:1987;450-455.
10. Flatau G., Lemichez E., Gauthier M., Chardin P., Paris S., Fiorentini C., Boquet P. Toxin-induced activation of the G protein p21 Rho by deamidation of glutamine. Nature. 387:1997;729-733.
11. Flatau G., Landraud L., Boquet P., Bruzzone M., Munro P. Deamidation of RhoA glutamine 63 by the Escherichia coli CNF1 toxin requires a short sequence of the GTPase switch 2 domain. Biochem. Biophys. Res. Commun. 267:2000;588-592.
12. Galàn J.E., Zhou D. Striking a balance. modulation of the actin cytoskeleton by Salmonella Proc. Natl. Acad. Sci. USA. 97:2000;8754-8761.
13. Hall A. Rho GTPases and the actin cytoskeleton. Science. 279:1998;509-514.
14. Hershko A., Ciechanover A. The ubiquitin system. Annu. Rev. Biochem. 67:1998;425-479.
15. Horiguchi Y. Escherichia coli cytotoxic necrotizing factors and Bordetella dermonecrotic toxin. the dermonecrosis-inducing toxins activating Rho small GTPases Toxicon. 39:2001;1619-1627.
16. Khan N.A., Wang Y., Kim K.J., Chung J.W., Wass C.A., Kim K.S. Cytotoxic necrotizing factor-1 contributes to Escherichia coli K1 invasion of the central nervous system. J. Biol. Chem. 277:2002;15607-15612.
17. Landraud L., Gauthier M., Fosse T., Boquet P. Frequency of Escherichia coli strains producing the cytotoxic necrotizing factor (CNF1) in nosocomial urinary tract infections. Lett. Appl. Microbiol. 30:2000;213-216.
18. Lemichez E., Flatau G., Bruzzone M., Boquet P., Gauthier M. Molecular localization of the Escherichia coli cytotoxic necrotizing factor CNF1 cell-binding and catalytic domains. Mol. Microbiol. 24:1997;1061-1070.
19. Lerm M., Selzer J., Hoffmeyer A., Rapp U.R., Aktories K., Schmidt G. Deamidation of Cdc42 and Rac by Escherichia coli cytotoxic necrotizing factor 1. activation of c-Jun N-terminal kinase in HeLa cells Infect. Immun. 67:1999;496-503. a.
20. Lerm M., Schmidt G., Goehring U.M., Schirmer J., Aktories K. Identification of the region of rho involved in substrate recognition by Escherichia coli cytotoxic necrotizing factor 1 (CNF1). J. Biol. Chem. 274:1999;28999-29004. b.
21. Li X., Bu X., Lu B., Avraham H., Flavell R.A., Lim B. The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient and modulates activities of other Rho GTPases by an inhibitory function. Mol. Cell. Biol. 22:2002;1158-1171.
22. Lockman H.A., Gillespie R.A., Baker B.D., Shakhnovich E. Yersinia pseudotuberculosis produces a cytotoxic necrotizing factor. Infect. Immun. 70:2002;2708-2714.
23. Low D., David V., Lark D., Schoolnik G., Falkow S. Gene clusters governing the production of hemolysin and mannose-resistant hemagglutination are closely linked in Escherichia coli serotype O4 and O6 isolates from urinary tract infections. Infect. Immun. 43:1984;353-358.
24. Manser E., Loo T.H., Koh C.G., Zhao Z.S., Chen X.Q., Tan L., Tan I., Leung T., Lim L. PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol. Cell. 1:1998;183-192.
25. Mulvey M.A., Schilling J.D., Martinez J.J., Hultgren S.J. Bad bugs and beleaguered bladders. interplay between uropathogenic Escherichia coli and innate host defenses Proc. Natl. Acad. Sci. USA. 97:2000;8829-8835.
26. Nobes C.D., Lauritzen I., Mattei M.G., Paris S., Hall A., Chardin P. A new member of the Rho family, Rnd1, promotes disassembly of actin filament structures and loss of cell adhesion. J. Cell Biol. 141:1998;187-197.
27. Olson M.F., Pasteris N.G., Gorski J.L., Hall A. Faciogenital dysplasia protein (FGD1) and Vav, two related proteins required for normal embryonic development, are upstream regulators of Rho GTPases. Curr. Biol. 6:1996;1628-1633.
28. Paterson H.F., Self A.J., Garrett M.D., Just I., Aktories K., Hall A. Microinjection of recombinant p21rho induces rapid changes in cell morphology. J. Cell Biol. 111:1990;1001-1007.
29. Pei S., Doye A., Boquet P. Mutation of specific acidic residues of the CNF1 T domain into lysine alters cell membrane translocation of the toxin. Mol. Microbiol. 41:2001;1237-1247.
30. Ren X.D., Kiosses W.B., Schwartz M.A. Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton. EMBO J. 18:1999;578-585.
31. Ridley A. Rho GTPases and cell migration. J. Cell Sci. 114:2001;2713-2722.
32. Sasakawa C., Yoshikawa M. A series of Tn5 variants with various drug-resistance markers and suicide vector for transposon mutagenesis. Gene. 56:1987;283-288.
33. Schmidt G., Sehr P., Wilm M., Selzer J., Mann M., Aktories K. Gln 63 of Rho is deamidated by Escherichia coli cytotoxic necrotizing factor-1. Nature. 387:1997;725-729.
34. Spoerner M., Herrmann C., Vetter I.R., Kalbitzer H.R., Wittinghofer A. Dynamic properties of the Ras switch I region and its importance for binding to effectors. Proc. Natl. Acad. Sci. USA. 98:2001;4944-4949.
35. Stebbins C.E., Galán J.E. Structural mimicry in bacterial virulence. Nature. 412:2001;701-705.